IIM-B flags future of healthcare at 5th Ayusmat summit
Bengaluru, Jul 21 (PTI) Indian Institute of Management Bangalore organised its fifth annual flagship healthcare leadership summit, Ayusmat 2025, on Monday.
Titled 'Healthcare 2030: Drivers of Disruption—Management, Machines or Markets', the event was hosted by the seventh cohort of the General Management Programme for Healthcare Executives (GMHE), said an official release.
GMHE is a specialised programme at IIMB designed for working professionals across various segments of the healthcare industry.
In his keynote address, Jawaid Akhtar, former additional chief secretary of health and family welfare, government of Karnataka, spoke about the growing pace of digitalisation, increasing workforce and economic pressures, and the rise of patient-centric models of care.
The event brought together a cross-section of stakeholders—including healthcare leaders and administrators, policymakers, technologists, startup entrepreneurs, and scholars—to discuss the seismic shifts transforming Indian healthcare and what the future may hold, the release added.
Prof U Dinesh Kumar, director-in-charge, IIMB, and Dr Amrut Kadam, deputy director, Rajiv Gandhi University of Health Sciences, were also present. PTI JR SSK
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
38 minutes ago
- Economic Times
Medtech firms flag inflated MRPs on imported devices
Indian manufacturers of medical devices have alleged that several private hospitals and retailers, in the chase for higher margins, are pushing sales of imported products, some of which carry inflated price tags or do not mention the maximum retail price (MRP). These imported devices of established brands account for about 65% of the medical devices sold in India, according to industry matter was discussed at a recent meeting with commerce and industry minister Piyush Goyal, industry executives told ET."It has been seen that the private hospitals and retailers preferentially push imported medical devices, often labelled with inflated or absent MRPs," a senior industry executive who attended the meeting told ET. "The hospitals are doing this to earn higher trade margins compared to affordable Indian made devices." The executive did not wish to be the meeting, representatives of domestic manufacturers discussed the procurement challenges the industry is facing in this regard. "They are making higher margins and more money. The consumer would bear the brunt and, hence, this issue was discussed during the meeting. The ministry has asked the NPPA (National Pharmaceutical Pricing Authority) to look into the matter," said another executive, requesting not to be named. Rajiv Nath, forum coordinator of Association of Indian Medical Device Industry (AiMeD), said domestic manufacturers face a stiff challenge in the market from imported devices despite offering the same product at rates that are 20-40% less, "as private hospitals and retailers are preferentially pushing imported established brands of medical devices, often carrying inflated prices or at times labels even without MRPs"."Indian manufacturers are forced to hike their labelled MRP to satisfy these buyers," he said domestic manufacturers have demanded that all import e-bills of lading should capture the import landed price as well as the MRP on the medical device, and any irrationally excessive MRP of 20 to 30 times of landed cost should be flagged for investigation for duty evasion and unfair trade practices.
Time of India
an hour ago
- Time of India
Medtech firms flag inflated MRPs on imported devices
Indian manufacturers of medical devices have alleged that several private hospitals and retailers, in the chase for higher margins, are pushing sales of imported products, some of which carry inflated price tags or do not mention the maximum retail price (MRP). These imported devices of established brands account for about 65% of the medical devices sold in India, according to industry sources. The matter was discussed at a recent meeting with commerce and industry minister Piyush Goyal, industry executives told ET. Explore courses from Top Institutes in Please select course: Select a Course Category Management CXO MCA Data Science PGDM Degree Cybersecurity Technology Healthcare MBA Design Thinking Public Policy healthcare Product Management others Project Management Others Digital Marketing Operations Management Finance Artificial Intelligence Leadership Data Science Data Analytics Skills you'll gain: Duration: 11 Months IIM Kozhikode CERT-IIMK General Management Programme India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK GMPBE India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta CERT-IIMC APSPM India Starts on undefined Get Details "It has been seen that the private hospitals and retailers preferentially push imported medical devices, often labelled with inflated or absent MRPs," a senior industry executive who attended the meeting told ET. "The hospitals are doing this to earn higher trade margins compared to affordable Indian made devices." The executive did not wish to be named. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now At the meeting, representatives of domestic manufacturers discussed the procurement challenges the industry is facing in this regard. "They are making higher margins and more money. The consumer would bear the brunt and, hence, this issue was discussed during the meeting. The ministry has asked the NPPA ( National Pharmaceutical Pricing Authority ) to look into the matter," said another executive, requesting not to be named. Live Events Rajiv Nath, forum coordinator of Association of Indian Medical Device Industry (AiMeD), said domestic manufacturers face a stiff challenge in the market from imported devices despite offering the same product at rates that are 20-40% less, "as private hospitals and retailers are preferentially pushing imported established brands of medical devices, often carrying inflated prices or at times labels even without MRPs". "Indian manufacturers are forced to hike their labelled MRP to satisfy these buyers," he said. Nath said domestic manufacturers have demanded that all import e-bills of lading should capture the import landed price as well as the MRP on the medical device, and any irrationally excessive MRP of 20 to 30 times of landed cost should be flagged for investigation for duty evasion and unfair trade practices.
News18
an hour ago
- News18
Cancer care projects launched in 3 Punjab districts
Agency: PTI Last Updated: Chandigarh, Jul 30 (PTI) The Punjab government, in partnership with WHO, has launched a pilot cancer care project each in Bathinda, Mohali, and Gurdaspur, Health Minister Balbir Singh said on Wednesday. This initiative is aimed at early detection, diagnosis, and treatment of oral, breast, and cervical cancers – three of the most prevalent and preventable cancers in India, he said. The move aligns with the National Programme for Prevention and Control of Non-Communicable Diseases, and strives to integrate cancer care across Punjab's public health system, right from Ayushman Arogya Kendras at the grassroots to advanced hospitals. In Punjab, at present, over 60 per cent of cancer cases are diagnosed at advanced stages, leaving limited scope for effective intervention, the minister said. 'Cancer does not mean death. It is very much curable if diagnosed in time. Early detection is the keystone of cancer care. This initiative is a reflection of our belief in health as a fundamental right and our resolve to build a resilient and inclusive health system for all," he said. Balbir Singh also claimed unhealthy lifestyles and poor dietary habits were critical contributors to rising cancer incidents, advised against leading a sedentary lifestyle. Dr Roderico H Ofrin, the WHO representative to India, praised the initiative, Mission Umeed, and said that it stands out as a leader in cancer care in the country. 'WHO is proud to be a partner in this important initiative, and will continue offering its full technical support to make this model a replicable success across India," he said. The pilot adopts a three-tier model and offers a wide range of interventions, such as universal screening of individuals aged 30 and above, bolstering frontline workers and clinical staff, follow-up and referral systems, and digital monitoring via the NP-NCD portal. PTI CHS VN VN view comments First Published: July 31, 2025, 00:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
